September 2017 – The CenterWatch Monthly : PDF
Is eConsent adoption poised to grow?
Activity in the eConsent sector has risen considerably during the past six months, with Medidata’s acquisition of electronic informed consent pioneer Mytrus and the entry of new market players, even though widespread industry adoption of the technology has appeared to have stalled.
Site selection a continuing conundrum
For many companies, searching for clinical trial sites begins with a look at paper-based and spreadsheet tools that document where they had held earlier trials. Returning to familiar sites allows clinical trial teams to work with principal investigators with whom they have built relationships over time.
Also in this issue:
- Planning for proactive pharmacovigilance
- Implementing end-to-end trial technology solutions
- Integrated delivery of CRO services
- Regulatory Update
- Month in Review
- FDA Actions
- Study Lead Opportunities
- New Drugs in the Pipeline